Kankerscreening: zegen of vloek?
Kritisch overzicht van de voor- en nadelen van kankerscreeningprogramma's.
Abstract (original)
Cancer screening seems intuitively logical: early detection to prevent worse outcomes. However, this article reveals the complexity behind this assumption. Cancer's linear growth model- on which early detection was based - proves outdated. Cancers grow at vastly different rates; some even stop or disappear spontaneously. The main problem is overdiagnosis: in Dutch breast cancer screening, approximately 2,000 women are treated annually for cancers that would never cause symptoms. Epidemiological data show a persistent increase in stage I cancers without a decline in stage IV cases - a sign of overdiagnosis. Screening has a Janus face: on one hand life-saving potential, on the other unnecessary treatments with side effects. Effectiveness must be proven through randomized trials that reduce cancer-specific and overall mortality. Citizens deserve honest information about this balance between intuition and scientific evidence. Core message: Screening only works if it reduces mortality, not merely by finding more cancers.
Dit artikel is een samenvatting van een publicatie in Nederlands tijdschrift voor geneeskunde. Voor het volledige artikel, alle details en referenties verwijzen wij u naar de oorspronkelijke bron.
Lees het volledige artikel